CD38 and Miyoshi myopathy: So far, several immune targets, including B-cell maturation antigen (BCMA), CD38, CD19, G-protein coupled receptor family C group 5 member D (GPRC5D), and Fc receptor-homolog 5 (FcRH5), have been considered suitable for bsAbs in MM [17].